Cargando…
The continuing need for therapeutic agents for respiratory syncytial virus infection
Respiratory syncytial virus infections recur throughout life despite induction of immunity by the first natural infection. An effective vaccine has long been sought but no vaccine is currently licensed, although promising candidates are currently being developed based on greater knowledge of the vir...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424541/ https://www.ncbi.nlm.nih.gov/pubmed/37574755 http://dx.doi.org/10.1177/20402066231194424 |